Albert Farrugia: The Past, Present and Future of Blood Plasma Fractionation
Albert Farrugia Clinical Professor, UWA Medical School, Surgery, shared an inspiring post on LinkedIn:
“It is one of the honours of my life to be associated with the two great names and dear friends with whom this work was produced-John Curling and Leni von Bonsdorff .
I was keen on us developing this project after a long period of hearing the founders of this industry being denigrated by a number of ambitious adventurers who frequently refer to Cohn fractionation as “bucket chemistry ” with no innovative effort since its inception, in order to tout alternatives which have foundered before seeing the light of day.
In this paper, the industry’s history is reviewed, alternative technologies are assessed, and areas such as disruptive therapies and pathogen reduction are discussed.
The paper is available on Open Access and we welcome comments.
And, as I always say when I lecture on plasma fractionation:
‘First there was Cohn, and then there was Curling’.”
Read the full article here.
Article: The past, present and future of blood plasma fractionation
Authors: Albert Farrugia, John Curling, Leni von Bonsdorff
Stay updated on all science in the field of hematology with Hemostasis Today.
-
Aug 18, 2025, 23:48Pulmonary Embolism Management: Experts Share Valuable Insights on Endovascular Today
-
Aug 18, 2025, 13:21Gehan Lotfy Khalifa and Colleagues Share a Egyptian Pediatric Guidelines for Childhood VTE
-
Aug 18, 2025, 09:45Mark Lewis: aPTT Pathway—What Activates What
-
Aug 18, 2025, 08:48William Aird: Physical Exam in Hit
-
Aug 17, 2025, 23:32Platelets Carry Tumor DNA! Powerful Potential for Liquid Biopsies and Precision Cancer Detection
-
Aug 18, 2025, 11:04Albert Farrugia: The Past, Present and Future of Blood Plasma Fractionation
-
Aug 18, 2025, 09:57Eugene Yang: When Should Prevention of Atherosclerosis Begin?
-
Aug 18, 2025, 09:34SIREN Study: Important Insights Hypertension and Low Vegetable Consumption Double Stroke Odds
-
Aug 18, 2025, 09:03Genetic Insights: FVIII A3 Variants and Inhibitor Risk
-
Aug 17, 2025, 11:34DAPT After PCI: Sex-Specific Strategies Unveiled
-
Aug 16, 2025, 14:42Mark Crowther Honors Davide Matino for Leading Promising Hemophilia Trial at McMaster University
-
Aug 14, 2025, 10:28Impressive 95% Clot Removal in a VTE Case: Symphony16F and Symphony24F Catheters
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Aug 17, 2025, 07:31Melissa Korn's story: Recognizing Pulmonary Embolism Symptoms Can Save Lives, NBCA
-
Aug 16, 2025, 14:18Christelle Orlando Highlights Breakthroughs in Thrombophilia Testing and AT Assays at ISTH 2025
-
Aug 15, 2025, 23:33Kacper Odziomek Excels in 2 Pharmacology Courses from Harvard Medical School
-
Aug 15, 2025, 03:44Call for Global Action on Bleeding Disorders from Baumann, Christoforou and Klamroth
-
Aug 14, 2025, 02:08Jordan Harry's Conversation on Cancer and Clot Risk with Thrombosis Canada